International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 2/28/2025 | 8/31/2024 | 2/29/2024 | |
|---|---|---|---|---|
| Market Cap | £244,281 | £248,631 | £250,477 | £265,938 |
| - Cash | £14,980 | £4,247 | £10,433 | £9,227 |
| + Debt | £29,607 | £35,738 | £22,827 | £27,669 |
| Enterprise Value | £258,908 | £280,122 | £262,871 | £284,380 |
| Revenue | £5,991 | £12,695 | £10,469 | £32,414 |
| % Growth | -52.8% | 21.3% | -67.7% | – |
| Gross Profit | £1,688 | £12,695 | £10,926 | £27,098 |
| % Margin | 28.2% | 100% | 104.4% | 83.6% |
| EBITDA | -£9,447 | £0 | £10,518 | -£631 |
| % Margin | -157.7% | 0% | 100.5% | -1.9% |
| Net Income | -£8,204 | £7,034 | £10,543 | £28,333 |
| % Margin | -136.9% | 55.4% | 100.7% | 87.4% |
| EPS Diluted | -0.23 | 0.19 | 0.29 | 0.73 |
| % Growth | -221.1% | -34.5% | -60.3% | – |
| Operating Cash Flow | £31,304 | -£2,925 | -£33,819 | £25,544 |
| Capital Expenditures | -£31,304 | £0 | £0 | £0 |
| Free Cash Flow | £0 | -£2,925 | -£33,819 | £25,544 |